New pain pill SBS-147 enters first human safety tests
NCT ID NCT07335913
First seen Jan 13, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This early-stage study tests the safety of an experimental oral drug called SBS-147 in 80 healthy adults aged 18-55. Some participants get the drug, others get a placebo. The study has two parts: one group takes a single dose, another takes it daily for a week. Researchers will monitor side effects and how the body processes the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AltaSciences, Inc
RECRUITINGCypress, California, 90630, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.